Related Experiment Video
Updated: May 28, 2026
09:44
Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen
Published on: November 27, 2019
Acute liver failure in neonates, infants and children
Denis Devictor1, Pierre Tissieres, Philippe Durand
1Neonatal and Pediatric Intensive Care Unit, Department of Pediatrics, APHP-Bicêtre Hospital, Paris 11-Sud University, 94275 Le Kremlin-Bicêtre, France. denis.devictor@bct.aphp.fr
Expert Review of Gastroenterology & Hepatology
|October 25, 2011
Summary
Acute liver failure (ALF) in children presents unique challenges, often lacking specific treatments. Early transplant referral and multidisciplinary care are crucial for improving survival rates in pediatric ALF cases.
Area of Science:
- Pediatric Hepatology
- Critical Care Medicine
- Transplantation
Background:
- Acute liver failure (ALF) is a rare, severe condition in children with distinct causes and presentations compared to adults.
- Current therapeutic options for promoting liver regeneration in pediatric ALF are limited.
- Determining the precise cause of ALF is frequently challenging.
Purpose of the Study:
- To review current knowledge on the epidemiology, pathobiology, and treatment of ALF in pediatric populations.
- To discuss recent controversies and management strategies for ALF in neonates, infants, and children.
- To highlight the importance of a multidisciplinary approach and timely transplant referral.
Main Methods:
- Comprehensive literature review of pediatric acute liver failure.
- Analysis of epidemiological data and etiologic spectrum.
- Evaluation of current treatment modalities and outcomes, including liver transplantation.
Main Results:
- Pediatric ALF exhibits a different etiologic spectrum and clinical course than adult ALF.
- Management necessitates a multidisciplinary approach focusing on complication prevention and early transplant evaluation.
- Liver transplantation improves survival but carries risks, with continued mortality observed during waiting periods and post-transplant.
Conclusions:
- Pediatric ALF requires specialized management due to its unique characteristics and limited specific therapies.
- Multidisciplinary care and timely liver transplantation are vital for improving outcomes.
- Ongoing research and discussion on controversies in pediatric ALF are essential for advancing patient care.
Related Concept Videos
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...